Analyst picks & changes

Centocor Inc.

(CNTO), Malvern, Penn.

Business: Cardiopulmonary

Cowen & Co. analyst Joyce Lonergan noted that positive data from Merck's

Aggrastat

GPIIb/IIIa

inhibitor could result in

Read the full 257 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE